Monoclonal antibody MAB-T88 is a human monoclonal immunoglobulin M antibody directed at the lipopolysaccharide of gram-negative bacteria. In this study, nine patients who were expected to become neutropenic from antineoplastic chemotherapy received an infusion of MAB-T88, three patients at each of three doses: 1, 4, and 8 mg/kg of body weight. MAB-T88 was shown to be safe, with an effective half-life in plasma of 25.4 h, and no patient developed immunoglobulin G antibody to MAB-T88.Bacterial endotoxins play a key role in septic shock by increasing the levels of interleukin-1 and tumor necrosis factor and by the humoral activation of at least four systems involved in the physiologic alterations that occur in patients with septic shock, i.e., complement, coagulation, fibrinolysis, and bradykinin (4,17 2,4,6, 24, 48, and 96 h after the start of the infusion; and on study day 7. Sera were obtained for analysis of the immune response to MAB-T88 before treatment and on study days 3, 7, 14, and 28.Human MAB-T88 was developed from a mouse-human heteromyeloma, as described previously (15). Briefly, human lymphocytes from a blood bank donor expressing 6-thioguanine resistance were fused with a mouse myeloma cell. The human-mouse nonsecreting hybrid (F3B6) was selected for with 6-thioguanine and ouabain, and B cells from a human spleen were fused with the human-mouse hybrid partner. An enzyme-linked immunosorbent assay (ELISA) was used to determine the concentration of MAB-T88 for pharmacokinetic analysis. A microdilution plate was coated with a mouse anti-MAB-T88 idiotype monoclonal antibody (2H6) at 5 ,ug/ml, incubated overnight, and washed in the morning. Monoclonal antibody 2H6 is highly specific for MAB-T88. Two hundred microliters of blocking buffer was added to each well, the plate was incubated for 2 h at ambient temperature, and the plate was washed and used immediately. The serum sample was diluted in phosphate-buffered saline to fall between 0.25 and 5.0 ng/ml for the assay. One hundred microliters of standards, controls, and samples was added to the appropriate wells of a microtiter plate. The